Items where authors include "Kearney, M."

Article

Critchlow, S. orcid.org/0000-0001-6862-765X, Bullement, A. orcid.org/0000-0001-7091-0972, Crabb, S. orcid.org/0000-0003-3521-9064 et al. (9 more authors) (2023) Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland. Future Oncology, 20 (8). pp. 459-470. ISSN 1479-6694

Kapetanakis, V., Prawitz, T., Schlichting, M. et al. (6 more authors) (2019) Assessment-schedule matching in unanchored indirect treatment comparisons of progression-free survival in cancer studies. PharmacoEconomics, 37 (12). pp. 1537-1551. ISSN 1170-7690

Conference or Workshop Item

Drozd, M. orcid.org/0000-0003-0255-4624, Bruns, A., Yuldasheva, N. et al. (12 more authors) (2024) Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis. In: ESC Congress 2024, 30 Aug - 02 Sep 2024, London, UK.

Proceedings Paper

Critchlow, S., Xiao, Y., Crabb, S. et al. (9 more authors) (2022) POSC4 Modeling health-related outcomes with avelumab as a first-line maintenance treatment following chemotherapy vs. best supportive care (BSC) for patients with locally advanced or metastatic urothelial cancer in the UK. In: Value in Health. Virtual ISPOR Europe 2021, 30 Nov - 03 Dec 2021, Virtual conference. Elsevier BV , S32-S33.